Last updated 2026-07-26
- Raised $10M Series A led by GreyBird Ventures, Dec 2024
- Raised $10M Seed round led by GreyBird Ventures, May 2024
- Raised $1M grant, Apr 2026
Total raised
$25.1M
Last: Grant 2026-05
Stage
Series A
Founded
2018
Headcount
36
HQ
Tel Aviv-Yafo, Israel
Sector
Health Tech & Life Sciences
About
NeuroKaire (formerly Genetika+) is a biotechnology company specializing in precision medicine in psychiatry and neurology. They have developed a personalized medical testing tool that uses a "brain-in-a-dish" technology to analyze patient-derived neurons, genetics, and medical history to identify optimal antidepressant treatments. This approach aims to eliminate the trial-and-error process in treating depression, leading to faster treatment, fewer side effects, and lower dosing. NeuroKaire's technology also provides pharmaceutical companies with tools for targeted drug discovery and development. NeuroKaire's R&D center, employing 25 people, is based in Tel Aviv, while they expanded to the US in 2023 and opened a commercial lab in Kearny, NJ.
Funding history · 7 rounds · $25.1M total
2026-04
Grant
$1.0M
2024-12
A Round
$10.0M
★ GreyBird VenturesMeron CapitalHoward MorganMichael ZeisserJumpspeed VenturesSapir Venture PartnersMichael Zeisser of FMZ Ventures
2024-05
Seed
$10.0M
★ GreyBird VenturesMeron CapitalJumpspeed Ventures
2022-08
Grant
$2.5M
2020-06
Grant
$1.0M
2019-02
Grant
$580K
2018-10
Grant
$40K
Headcount over time
From 4 (2019-05) to 41 (2026-03) · +37 (+925%) · 18 points · source: Finder history + radar grounding
Q&A
- What is NeuroKaire's primary focus?
- NeuroKaire is a biotechnology company specializing in precision medicine in psychiatry and neurology, aiming to transform depression medication selection by understanding individual patient responses.
- When was NeuroKaire founded?
- NeuroKaire was founded in 2018.
- How many employees does NeuroKaire currently have?
- NeuroKaire has 36 employees, falling within the 11-50 employee bucket.
- What was NeuroKaire's most recent funding round?
- NeuroKaire secured a Grant round in May 2026, raising $1,000,000.
- Which investors participated in NeuroKaire's A Round in December 2024?
- GreyBird Ventures led NeuroKaire's A Round in December 2024.
- What significant funding did NeuroKaire receive in July 2022?
- In July 2022, NeuroKaire received a Grant of $17,300,000 from the European Commission's European Innovation Council.
- Where are NeuroKaire's main operations located?
- NeuroKaire's R&D center is in Tel Aviv, Israel, and they expanded to the US in 2023 with a commercial lab in Kearny, NJ.
- What is the core technology behind NeuroKaire's personalized medical testing tool?
- NeuroKaire's personalized medical testing tool utilizes "brain-in-a-dish" technology to analyze patient-derived neurons, genetics, and medical history.
Team · 2
Talia Cohen Solal
Founder · Founder & CEO
Daphna Laifenfeld
Founder · Founder & CSO
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesDigital HealthcareDigital Medical DiagnosticsMedical Decision Support
Technologies
Artificial IntelligenceMachine Learning
Target customers
Healthcare & Life SciencesHealthcarePatientsProvidersLife SciencesPharmaceuticals
Business model
B2B2CB2B
Highlights
1 PatentsVerified
Tags
clinical-trialsneurologygenetic-engineeringpharma-companiesdeep-learningmental-healthmachine-learningdigital-healthcaremedicationdoctorspersonalizationtestingartificial-intelligenceclinicshealthcare-providerspatientsneurosciencehospitalspsychiatrydecision-support
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | neurokaire.com |
|---|---|
| linkedin.com/company/28148811 | |
| facebook.com/genetikaplus | |
| YouTube | youtube.com/channel/UCPrzpeKog5qfli5T6faeSTw |
Identifiers & details
| Legal name | GenetikaPlus Ltd |
|---|---|
| Former names | Genetika+, GENETIKA RX |
| Founded | 2018 |
| Employees (exact) | 36 |
| Offices | Kearny |
Radar intelligence
Web history (Wayback)
| Domain | neurokaire.com |
|---|
Certificate / subdomain footprint
| Subdomains | 10 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 515897205 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2018-08-30 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2025 |
| Active charges / liens | 0 |
| Registry events | 0 |
| Registered address | אלון יגאל 126 תל אביב - יפו |